{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:07:34Z","timestamp":1777482454668,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Children's Medical Research Foundation"},{"name":"The Sanfilippo Research Foundation"},{"name":"The Sanfilippo Children's Research Foundation"},{"name":"Ohio State University\/NCH Center for Clinical and Translational Science","award":["UL1TR001070"],"award-info":[{"award-number":["UL1TR001070"]}]},{"name":"Clinical and Translational Science Award"},{"name":"Cure Sanfilippo Foundation"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ymgme.2016.08.002","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T20:46:49Z","timestamp":1471898809000},"page":"239-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design"],"prefix":"10.1016","volume":"119","author":[{"given":"K.V.","family":"Truxal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.A.","family":"McNally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.L.","family":"Kunkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.A.","family":"Zumberge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"Aylward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.N.","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.P.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Corridore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.L.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M.","family":"Flanigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2016.08.002_bb0005","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2014"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s13353-014-0262-5","article-title":"Prevalence rates of mucopolysaccharidoses in Poland","volume":"56","author":"Jurecka","year":"2015","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4439(99)00118-0","article-title":"Heparan N-sulfatase gene: two novel mutations and transient expression of 15 defects","volume":"1501","author":"Esposito","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0020","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1073\/pnas.93.12.6101","article-title":"The molecular basis of Sanfilippo syndrome type B","volume":"93","author":"Zhao","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0025","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/508068","article-title":"Identification of the gene encoding the enzyme deficient in mucopolysaccharidosis IIIC (Sanfilippo disease type C)","volume":"79","author":"Fan","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0888-7543(02)00014-9","article-title":"Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase","volume":"81","author":"Mok","year":"2003","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0387-7604(85)80008-5","article-title":"Neuropathological study and chemico-pathological correlation in sibling cases of Sanfilippo syndrome type B","volume":"7","author":"Tamagawa","year":"1985","journal-title":"Brain and Development"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","article-title":"Sanfilippo syndrome: a mini-review","volume":"31","author":"Valstar","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0045","first-page":"638","article-title":"Broad functional correction of molecular impairments by systemic delivery of scAAVrh74-hSGSH gene delivery in MPS IIIA mice Molecular therapy","volume":"23","author":"Duncan","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0050","first-page":"1025","article-title":"Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery Molecular therapy","volume":"19","author":"Fu","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0055","first-page":"72","article-title":"Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates human gene therapy","volume":"25","author":"Murrey","year":"2014","journal-title":"Clin. Dev."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0060","first-page":"228","article-title":"A GLP-compliant toxicology and biodistribution study: systemic delivery of an rAAV9 vector for the treatment of mucopolysaccharidosis IIIB human gene therapy","volume":"26","author":"Meadows","year":"2015","journal-title":"Clin. Dev."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0065","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/hmg\/ddu727","article-title":"Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy","volume":"24","author":"Ribera","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0070","first-page":"254","article-title":"Liver production of sulfamidase reverses peripheral and ameliorates CNS pathology in mucopolysaccharidosis IIIA mice Molecular therapy","volume":"20","author":"Ruzo","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0075","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1172\/JCI66778","article-title":"Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy","volume":"123","author":"Haurigot","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0080","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF01799255","article-title":"A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type A (MPS IIIA)","volume":"19","author":"Karpova","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0085","series-title":"Techniques in Diagnostic Human Biochemical Genetics - a Laboratory Manual","first-page":"567","article-title":"Enzymatic diagnosis of selected mucopolysaccharidoses: Hunter, Morquio type A, and Sanfilippo types A, B, C, and D, and procedures for measurement of 35SO4-glycosaminoglycans","author":"Thompson","year":"1991"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0090","series-title":"Leiter International Performance Scale-Third Edition","author":"Roid","year":"2013"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0095","series-title":"Leiter International Performance Scale-Revised Edition","author":"Roid","year":"1997"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0100","series-title":"Mullen Scales of Early Learning Manual","author":"Mullen","year":"1995"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0105","series-title":"Manual for the ASEBA Preschool Forms & Profiles","author":"Achenbach","year":"2000"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0110","series-title":"Manual for the ASEBA School-Age Forms & Profiles","author":"Achenbach","year":"2001"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0115","series-title":"Abas Ii","author":"Harrison","year":"2003"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0120","series-title":"Vineland Adaptive Behavior Scales, Second Edition: Survey Forms Manual","author":"Sparrow","year":"2005"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005650-199902000-00003","article-title":"PedsQL: the measurement model for the Pediatric Quality of Life Inventory","volume":"37","author":"Varni","year":"1999","journal-title":"Med. Care"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0130","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory Version 4.0","volume":"39","author":"Varni","year":"2001","journal-title":"Med. Care"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0135","series-title":"Pediatric Evaluation of Disability Inventory: Development, Standardization and Administration Manual","author":"Haley","year":"1992"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0140","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1399-3046.2011.01624.x","article-title":"A formula for determining the standard liver volume in children: a special reference for neonates and infants","volume":"16","author":"Saeki","year":"2012","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0145","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2214\/ajr.160.5.8470587","article-title":"Volume of the spleen in children as measured on CT scans: normal standards as a function of body weight","volume":"160","author":"Schlesinger","year":"1993","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.survophthal.2007.08.018","article-title":"Pediatric idiopathic intracranial hypertension","volume":"52","author":"Rangwala","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpeds.2011.02.038","article-title":"Correction of cerebrospinal fluid protein for the presence of red blood cells in children with a traumatic lumbar puncture","volume":"159","author":"Nigrovic","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0160","first-page":"33","article-title":"Mullen scales of early learning: the utility in assessing children diagnosed with autism spectrum disorders, cerebral palsy, and epilepsy","volume":"2","author":"Burns","year":"2013","journal-title":"Appl. Neurophysiol."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1073191112437594","article-title":"Nonverbal cognitive development in children with cochlear implants: relationship between the Mullen Scales of Early Learning and later performance on the Leiter International Performance Scales-Revised","volume":"21","author":"Caudle","year":"2014","journal-title":"Assessment"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejrad.2008.02.035","article-title":"(1) H MR spectroscopy in pediatrics","volume":"67","author":"Dezortova","year":"2008","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0175","series-title":"Clinical Applications of Proton MR Spectroscopy, CT and MRI of the Whole Body","author":"Haaga","year":"2009"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1203\/01.PDR.0000129661.40499.12","article-title":"Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice","volume":"56","author":"Gliddon","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0185","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/138920111795542651","article-title":"Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategies","volume":"12","author":"de Ruijter","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0190","article-title":"Adeno-associated viral vectors for the treatment of hemophilia","author":"High","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-2094-7-39","article-title":"Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response","volume":"7","author":"Killedar","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/8904_2013_269","article-title":"Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndrome","volume":"13","author":"Delaney","year":"2014","journal-title":"JIMD Reports"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0205","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/13803395.2013.804035","article-title":"Mucopolysaccharidosis Type IIIA presents as a variant of Kluver-Bucy syndrome","volume":"35","author":"Potegal","year":"2013","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0210","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ymgme.2015.02.008","article-title":"Quantifying behaviors of children with Sanfilippo syndrome: the Sanfilippo Behavior Rating Scale","volume":"114","author":"Shapiro","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115304","article-title":"Comparison of inter subject variability and reproducibility of whole brain proton spectroscopy","volume":"9","author":"Veenith","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2016.08.002_bb0220","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2015.11.079","article-title":"A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA","volume":"170","author":"Shapiro","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2016.08.002_bb0225","doi-asserted-by":"crossref","first-page":"16036","DOI":"10.1038\/mtm.2016.36","article-title":"Functional correction of neurological and somatic disorders at later stages ofdisease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery","volume":"3","author":"Fu","year":"2016","journal-title":"Mol. Ther. MethodsClin. Dev."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216301846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216301846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T03:45:49Z","timestamp":1589687149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719216301846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1096719216301846"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.08.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}